Florida Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$207K Sell
8,616
-591
-6% -$15.5K 0.04% 348
2026
Q1
$259K Sell
9,207
-5,549
-38% -$148K 0.06% 273
2025
Q4
$366K Buy
+14,756
New +$372K 0.1% 186
2025
Q3
Sell
-8,568
Closed -$208K 288
2025
Q2
$208K Sell
8,568
-1,149
-12% -$26.8K 0.07% 249
2025
Q1
$246K Buy
+9,717
New +$254K 0.1% 208
2024
Q1
Sell
-7,088
Closed -$204K 131
2023
Q4
$204K Buy
+7,088
New +$214K 0.19% 104

Other funds holding PFE

Florida Financial Advisors's PFE Position: Q2 2026 in Review

Florida Financial Advisors reduced its Pfizer (PFE) stake by 6.4% in Q2 2026, selling an estimated $15.5K and leaving 8,616 shares worth $207K. The position accounts for 0.04% of the portfolio, ranked #348.

Florida Financial Advisors first reported a position in PFE in Q4 2023 and has held it in 6 quarters since. The position peaked at $366K in Q4 2025. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Florida Financial Advisors held 8,616 shares of Pfizer worth $207K as of Q2 2026.
  • Florida Financial Advisors sold 591 Pfizer shares in Q2 2026, an estimated $15.5K.
  • Pfizer made up 0.04% of Florida Financial Advisors's portfolio in Q2 2026, its #348 holding.
  • Florida Financial Advisors first reported a position in Pfizer in Q4 2023 and has held it in 6 quarters since.
  • Florida Financial Advisors's Pfizer position peaked at $366K in Q4 2025.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Florida Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.